ArticleCancer biology & therapy2015

An exceptional overall survival using bevacizumab beyond progression in a patient with non-small cell lung cancer.

Giandomenico Roviello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.